Snowball logo
logo
GEKA_logo

Genomma Lab Internacional S.A.B. de C.V

0.905+0.045  (5.23%)

Frequently asked questions

What sector does Genomma Lab Internacional S.A.B. de C.V (GEKA) operate in?

Genomma Lab Internacional S.A.B. de C.V belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Genomma Lab Internacional S.A.B. de C.V (GEKA) current stock price?

As of the latest data, Genomma Lab Internacional S.A.B. de C.V stock price is €0.91, with a previous close of €0.86. Genomma Lab Internacional S.A.B. de C.V gained €0.05 in the last trading session, representing a 5.23% increase.

What is Genomma Lab Internacional S.A.B. de C.V (GEKA) current market capitalization?

Genomma Lab Internacional S.A.B. de C.V market cap is approximately 881.28 million.

What is Genomma Lab Internacional S.A.B. de C.V (GEKA) Earnings Per Share (EPS)?

The trailing EPS is €0.08.

What is Genomma Lab Internacional S.A.B. de C.V (GEKA) Price-to-Earnings (P/E) ratio?

Genomma Lab Internacional S.A.B. de C.V current P/E ratio is 11.31.

Does Genomma Lab Internacional S.A.B. de C.V (GEKA) pay dividends?

Yes. Genomma Lab Internacional S.A.B. de C.V pays quarterly dividends with an annualized yield of 0.21% and an estimated annual payout of €0.04 per share.

When is the next ex-dividend date for Genomma Lab Internacional S.A.B. de C.V (GEKA)?

The next ex-dividend date is scheduled for June 30, 2026.

When is Genomma Lab Internacional S.A.B. de C.V (GEKA) next earnings report?

Genomma Lab Internacional S.A.B. de C.V is expected to release its next earnings report on March 31, 2026.

What is Genomma Lab Internacional S.A.B. de C.V (GEKA) beta (volatility) score?

Genomma Lab Internacional S.A.B. de C.V has a beta of 0.292, indicating lower volatility than the overall market.